Scholars Central

Conference abstractPublished 20 Oct 2014

Tumor control by genetically engineered CD8+ and CD4+ T cells

Authors: Immanuel Luescher

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

This lecture will focus on tumor control by genetically engineered CD8+ and CD4+ T cells. A critical overview of different strategies of cancer gene therapies including adoptive transfer of autologous of CD8+ and CD4+ T cells transduced with genes coding for affinity optimized T cell receptors (TCR) or chimeric antigen receptors (CAR) will be presented. Detailed mechanistic studies will be discussed on how adoptive transfer of tumor-specific CD8+ T cells engineered to express high FasL and IFNγ expression and CAR engineered CD4+ T cells, respectively, mediate complete and permanent tumor eradication. In both cases the transferred T cells reprogrammed the tumor environment from a suppressive one to one supportive for the induction and amplification of endogenous tumor-specific T cell immunity and capable to destroy established tumors. Future perspectives will be discussed, how tumor microenvironments can be manipulated to achieve tumor control by altering balance between immunity and suppression.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Immanuel Luescher”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels